AG真人官方

Clearside Biomedical, Inc. (CLSD) has issued a Definitive Proxy Statement (DEF 14A) for a Special Meeting on 29 Aug 2025. The Board is asking holders of the 78.5 m outstanding shares (record date: 28 Jul 2025) to approve a single corporate action:

• Proposal 1 鈥� Reverse Stock Split & Authorized Share Reduction: authorises the Board, at its discretion within 12 months, to combine shares in any ratio from 1-for-5 to 1-for-15 and simultaneously cut authorised common shares proportionately from the current 400 m down to 80 m鈥�26.7 m, preserving par value ($0.001).

Rationale: CLSD has been out of compliance with Nasdaq鈥檚 $1.00 minimum bid price since 7 Feb 2025 and expects delisting notice after 6 Aug 2025. Management believes a higher share price following the reverse split is the most practical path to regain compliance and maintain Nasdaq Global Market listing, thereby protecting liquidity and financing options.

Voting mechanics: Proposal passes with a simple majority of votes cast; because it is deemed 鈥渞outine鈥� by NYSE rules, brokers may vote uninstructed street-name shares. No broker non-votes are expected. Quorum is >50% of outstanding shares (鈮�39.26 m). No dissenters鈥� rights apply.

Effects: Share counts, option pools and ATM capacity will shrink proportionally; fractional shares will be cashed out at the 5-day average market price. Ownership percentages and rights remain unchanged. The Board may abandon or defer the split if price compliance is regained independently.

Horizon Space Acquisition I Corp. (NASDAQ: HSPOU) has secured a one-month extension to complete its initial business combination. On 25 Jul 2025, Squirrel Enlivened (Hong Kong) Technology Ltd. (鈥淪quirrel HK鈥�) deposited $120,000 into HSPO鈥檚 trust account, allowing the deadline to move from 27 Jul 2025 to 27 Aug 2025. The deposit represents the first of up to five optional monthly extensions鈥攅ach costing $120,000鈥攖hat could push the outside date to 27 Dec 2025.

In consideration for the payment, HSPO issued an unsecured, zero-interest promissory note to Squirrel HK for the same amount (Exhibit 10.1). The principal is due at the earlier of (i) consummation of the SPAC鈥檚 business combination with Squirrel Enlivened Technology Co., Ltd. and affiliates (collectively, the 鈥淪quirrel Companies鈥�) or (ii) HSPO鈥檚 termination date. Events of default include non-payment within five business days of maturity, bankruptcy, breach, cross-defaults, enforcement actions or illegality, each of which could accelerate repayment.

The filing constitutes both an Entry into a Material Definitive Agreement (Item 1.01) and the Creation of a Direct Financial Obligation (Item 2.03). Although the $120k note is immaterial relative to SPAC trust assets, the extension averts near-term liquidation and preserves the pending merger announced 16 Sep 2024. Shareholders should monitor future extension fees, redemption levels and SEC filings (Form F-4/proxy) as key determinants of deal viability.

On 07/15/2025, CVI Investments, Inc. and its investment manager Heights Capital Management, Inc. jointly filed a Schedule 13G reporting a passive ownership of 1,000,000 BriaCell Therapeutics Corp. common shares (CUSIP 107930208). The stake equals 5.7 % of the 17.55 M shares outstanding, as cited in BriaCell鈥檚 July 2025 prospectus. Each Reporting Person claims 0 sole and 1,000,000 shared voting and dispositive power. Both entities disclaim beneficial ownership beyond their pecuniary interest and certify the shares were not acquired to influence control. Signatory: Sarah Travis (Heights Capital) on 07/22/2025. No group arrangements, subsidiaries, or additional controlling interests are disclosed.

Ciena Corporation (CIEN) has filed a Form 144 indicating that an insider plans to sell 734 common shares through Morgan Stanley Smith Barney LLC on or about 15 July 2025 via the NYSE. The proposed transaction is valued at $60,606.38 and represents less than 0.001 % of CIEN鈥檚 141,367,218 shares outstanding. The shares were acquired as restricted stock on 20 June 2025. No other insider sales were reported in the last three months, and the filing contains no additional financial or operational disclosures.

Ciena Corporation (CIEN) has filed a Form 144 indicating that an insider plans to sell 734 common shares through Morgan Stanley Smith Barney LLC on or about 15 July 2025 via the NYSE. The proposed transaction is valued at $60,606.38 and represents less than 0.001 % of CIEN鈥檚 141,367,218 shares outstanding. The shares were acquired as restricted stock on 20 June 2025. No other insider sales were reported in the last three months, and the filing contains no additional financial or operational disclosures.